| Volume: | NA |
|---|---|
| Day's Low: | NA |
| 52-wk Low: | $27.01 |
| Previous Close: | $58.94 |
| Dividend: | $0.00 |
| Market Cap: | 3,436,800 |
| Avg Volume: | 2,036,100 |
|---|---|
| Day's High: | NA |
| 52-wk High: | $59.50 |
| Open Price: | NA |
| Yield: | 0.00% |
| P/E (Forward): | 37.07 |
| 4:54 PM | 3/19/2010 | Astellas Changes 2 Nominees For Election To OSI Pharma Board |
| 6:38 PM | 3/17/2010 | Roche CEO Touts Pipeline, Remains Open To More Deals |
| 3:28 PM | 3/15/2010 | 2nd UPDATE: OSI Rejects $3.5 Billion Astellas Offer, Talks With Others |
| 1:56 PM | 3/15/2010 | UPDATE: OSI Rejects $3.5 Billion Astellas Offer, Talking With Others |
| 9:13 AM | 3/15/2010 | OSI Pharma Rejects Astellas $3.5 Billion Takeover Offer |
| 10:30 PM | 3/2/2010 | ASIA MARKETS: Japanese Drug Makers Put Up A Fight |
| 1:56 PM | 3/2/2010 | CORRECT: Astellas Begins $3.5 Billion Tender Offer For OSI Pharma |
| 3/20/2010 | The Unusual Suspects (ADBE, AIXG, GME, HAS, BBY, CIEN, LGF, ORCL, OSIP, PALM, SOMX, TEVA, TIF, CSCO, PFE, AMGN, RIMM) (24/7 Wall St) |
| 3/19/2010 | BioHealth Business Daily (APPA, GENZ, GENT, MRK, OSIP, OXGN, SOMX, THRX, CLDX) (24/7 Wall St) |
| 3/18/2010 | BioHealth Business Daily (APPA, ARIA, MDVN, OSIP, SOMX, TEVA) (24/7 Wall St) |
| 3/16/2010 | Corporate Watch (WSJ.com) |
| 3/16/2010 | Astellas to Press on With OSI Bid (WSJ.com) |
| 3/15/2010 | OSI Pharmaceuticals Rejects Offer from Astellas (Fox Business) |
| 3/15/2010 | Drug stocks up as OSI rejects $3.5 billion bid (MarketWatch.com) |
| 3/12/2010 | Maybe April will be a better month for the drug giant. (The Motley Fool) |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.48 | 0.44 | 9.09 |
| EPS, GAAP | 0.43 | 5.47 | -92.14 |
| Consensus Estimate | 0.43 | 0.48 | -10.42 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 1.62 | 1.50 | 8.00 |
| EPS, GAAP | 1.29 | 7.24 | -82.18 |
| Consensus Estimate | 1.43 | NA | NA |
| OSIP | Industry Average | |
| P/E (TTM) | 45.69 | 59.70 |
| P/E (Forward) | 37.07 | 2.80 |
| PEG Ratio | 2.75 | 0.14 |
| Price/Sales | 8.32 | 4.38 |
| Beta | 0.55 | 0.62 |